Skip to main content
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
58.19
+1.19 (2.09%)
At close: May 1, 2024, 4:00 PM
61.00
+2.81 (4.83%)
After-hours: May 1, 2024, 6:50 PM EDT

Janux Therapeutics Revenue

In the year 2023, Janux Therapeutics had annual revenue of $8.08M, a decrease of -6.14%. Revenue in the quarter ending December 31, 2023 was $2.46M, a -13.50% decrease year-over-year.

Revenue (ttm)
$8.08M
Revenue Growth
-6.14%
P/S Ratio
371.90
Revenue / Employee
$126,297
Employees
64
Market Cap
3.01B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.08M-529.00K-6.14%
Dec 31, 20228.61M4.98M136.79%
Dec 31, 20213.64M--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.74B
Amedisys 2.25B
Evolent Health 1.96B
Progyny 1.09B
Sotera Health Company 1.05B
Azenta 641.02M
Amicus Therapeutics 399.36M
Immunocore Holdings 249.43M
Revenue Rankings

JANX News

More News